Mark Kay

14PUBLICATIONS
51CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsTransgenesisGene and molecular therapyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 24, 2026
NEAT1 remodeling rewires the MYC degradation pathway.

|Mar 30, 2026
First-in-human nuclease-free homologous recombination-dependent gene editing in pediatric patients with methylmalonic acidemia: results of a phase 1/2 study.

Jirair K Bedoyan, Thomas Morgan, Angela Sun

|Dec 11, 2025
Species-specific AAVR dominates species-tropism of adeno-associated virus (AAV) vectors.

Mark Kay, Yuqian Jiang, Yiming Liu

|Nov 24, 2025
Integrated AAV optimization enables efficient gene delivery to kidney in murine and human tissue.

Fernando Gomez Garcia, Miriam Rivera Moreno, Shashank Chetty

|Oct 03, 2025
Stereo-random oligonucleotides enable efficient recruitment of ADAR in vitro and in vivo.

Laura S Pfeiffer, Tobias Merkle, Paul Vogel

|Jan 27, 2025
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use.

William McKeown, Cedric Hermans, Carmen Unzu

Pageof 3

Frequent Collaborators

3 joint publications

Katja Pekrun

2 joint publications

Shinnosuke Tsuji

1 joint publications

Yichi Su

1 joint publications

Namdoo Kim